Effect of lovastatin on coxsackievirus B3 infection in human endothelial cells - Wikidata - wikimedia - TriplyDB

Effect of lovastatin on coxsackievirus B3 infection in human endothelial cells

Effect of lovastatin on coxsackievirus B3 infection in human endothelial cells

http://www.wikidata.org/entity/Q28303547

about

Type I Interferon Counteracts Antiviral Effects of Statins in the Context of Gammaherpesvirus Infection.Lovastatin enhances adenovirus-mediated TRAIL induced apoptosis by depleting cholesterol of lipid rafts and affecting CAR and death receptor expression of prostate cancer cells.

P2860

Q36694053-7D778108-40AE-4B7A-8CB9-2BC80602DB59 Q38918249-7F7A2F49-E3E6-411F-A490-2E1455DC6CDB

P2860

Effect of lovastatin on coxsackievirus B3 infection in human endothelial cells

http://www.wikidata.org/entity/Q28303547

description

2014 nî lūn-bûn

@nan

2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Effect of lovastatin on coxsackievirus B3 infection in human endothelial cells

@ast

Effect of lovastatin on coxsackievirus B3 infection in human endothelial cells

@en

Effect of lovastatin on coxsackievirus B3 infection in human endothelial cells

@nl

type

label

Effect of lovastatin on coxsackievirus B3 infection in human endothelial cells

@ast

Effect of lovastatin on coxsackievirus B3 infection in human endothelial cells

@en

Effect of lovastatin on coxsackievirus B3 infection in human endothelial cells

@nl

prefLabel

Effect of lovastatin on coxsackievirus B3 infection in human endothelial cells

@ast

Effect of lovastatin on coxsackievirus B3 infection in human endothelial cells

@en

Effect of lovastatin on coxsackievirus B3 infection in human endothelial cells

@nl

P1433

Q28303547-604B7E71-01D0-42E4-8B86-9BC8DB0929BA

P1476

Q28303547-04E8C1DE-2CED-4626-A796-ADE2E748CF62

P2093

Q28303547-19DBE1F9-DD68-49D0-86ED-E101AC517BA2

Q28303547-799EABDE-BAEE-4FAD-BDED-35E9C357A1E9

Q28303547-92B1CB95-6684-4297-BB63-A0D507352A7A

Q28303547-A5BD0FD5-EADE-400B-AAFF-16C4BA9F3696

Q28303547-C3DAA5DB-1290-4D8C-9A4A-C0AEB10E22AD

Q28303547-D83E1EE6-45D5-4B39-B99B-6265F4963997

Q28303547-F1E836EA-CAC0-43AA-8BF1-67F297DD9CE1

P2860

Q28303547-045B8EF4-4725-4C43-B67F-B0ACE48FD554

Q28303547-0650E397-85D2-4D3A-B0A8-6AADF6DD4FDD

Q28303547-103470F9-840A-4180-9A9B-8B7F5FFC22FF

Q28303547-171505A4-CD44-4AB7-B6D1-ED1845F97782

Q28303547-196694E1-1719-4855-867A-D92E3F9196FB

Q28303547-1BFDDE9A-F85E-47C2-9939-2441D3997C5F

Q28303547-2852AF79-CADA-479F-A49E-D54734CA4B8A

Q28303547-29122C44-438A-4FD0-9B0E-5E62027FA75D

Q28303547-29A92E42-C17F-4BA1-84E4-862B287350BA

Q28303547-29F6BDEE-9C47-4323-8200-17EA9AC64F8F

P2888

Q28303547-D99A5F3C-6B97-404E-873A-754C0BD3F982

P304

Q28303547-39AFC2AC-AFBA-444C-8A4E-7B30850C7813

P31

Q28303547-B13D3BBA-CB3E-4660-87BD-BB8EF1A445E9

P356

Q28303547-31BCC4D2-8E98-44AD-924F-06FD26FBD279

P407

Q28303547-40E0F7FD-3CF7-400A-89E4-27B38AD6B45C

P433

Q28303547-BD65AA70-986A-4170-AF6D-5F111CCD36AA

P478

Q28303547-40E69B95-A485-492E-9E7B-FBF3F6A30ED8

P50

Q28303547-47CB47A2-6039-4335-8AB7-0AD4217B8D5A

P577

Q28303547-8AA7DFB4-AA79-4B8C-B374-D3998B4DFFC4

P5875

Q28303547-E84EEC46-1F04-4B93-8F8C-EAB4FECE035A

P6179

Q28303547-148BAFE1-20D9-430A-8DF1-9BE733910115

P698

Q28303547-B1F1C704-C18B-4E94-9B7F-07558759226A

P921

Q28303547-4E48E699-7051-4FAA-8D06-4360BBA75927

Q28303547-87185105-4CB5-4AAA-B27E-3DE983CB73BA

P356

S00011-013-0695-Z

P1433

Inflammation Research

P1476

Effect of lovastatin on coxsackievirus B3 infection in human endothelial cells

@en

P2093

Bianca Werner

http://www.w3.org/2001/XMLSchema#string

Carsten Funke

http://www.w3.org/2001/XMLSchema#string

Cornelia Piper

http://www.w3.org/2001/XMLSchema#string

Dieter Horstkotte

http://www.w3.org/2001/XMLSchema#string

Karsten Niehaus

http://www.w3.org/2001/XMLSchema#string

Martin Farr

http://www.w3.org/2001/XMLSchema#string

Sven Dittmann

http://www.w3.org/2001/XMLSchema#string

P2860

The coxsackievirus and adenovirus receptor is a transmembrane component of the tight junction

Neutrophil migration across tight junctions is mediated by adhesive interactions between epithelial coxsackie and adenovirus receptor and a junctional adhesion molecule-like protein on neutrophils

HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses

Isoform-specific expression of the Coxsackie and adenovirus receptor (CAR) in neuromuscular junction and cardiac intercalated discs

The evolutionary history of effectors downstream of Cdc42 and Rac.

Expression of coxsackie adenovirus receptor and alphav-integrin does not correlate with adenovector targeting in vivo indicating anatomical vector barriers

Receptor for the group B coxsackieviruses and adenoviruses: CAR

Antiviral effect of Bosentan and Valsartan during coxsackievirus B3 infection of human endothelial cells

In vivo half-life of a protein is a function of its amino-terminal residue

Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5

P2888

s00011-013-0695-z

P304

267-76

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00011-013-0695-Z

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

63

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259247254

http://www.w3.org/2001/XMLSchema#string

P6179

1036934878

http://www.w3.org/2001/XMLSchema#string

P698

24316867

http://www.w3.org/2001/XMLSchema#string

P921